BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun H, Feng J, Tang L. Function of TREM1 and TREM2 in Liver-Related Diseases. Cells 2020;9:E2626. [PMID: 33297569 DOI: 10.3390/cells9122626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Pan S, Li Y, He H, Cheng S, Li J, Pathak JL. Identification of ferroptosis, necroptosis, and pyroptosis-associated genes in periodontitis-affected human periodontal tissue using integrated bioinformatic analysis. Front Pharmacol 2022;13:1098851. [PMID: 36686646 DOI: 10.3389/fphar.2022.1098851] [Reference Citation Analysis]
2 Xu Q, Wang C, Yin G. Immune-related gene signature to predict TACE refractoriness in patients with hepatocellular carcinoma based on artificial neural network. Front Genet 2022;13:993509. [PMID: 36685822 DOI: 10.3389/fgene.2022.993509] [Reference Citation Analysis]
3 Wang J, Li Z. TREM2 Is a Prognostic Biomarker and Correlated with an Immunosuppressive Microenvironment in Thyroid Cancer. Disease Markers 2022;2022:1-16. [DOI: 10.1155/2022/1807386] [Reference Citation Analysis]
4 Listopad S, Magnan C, Asghar A, Stolz A, Tayek JA, Liu ZX, Morgan TR, Norden-Krichmar TM. Differentiating between liver diseases by applying multiclass machine learning approaches to transcriptomics of liver tissue or blood-based samples. JHEP Rep 2022;4:100560. [PMID: 36119721 DOI: 10.1016/j.jhepr.2022.100560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sigalov AB. Inhibition of TREM-2 Markedly Suppresses Joint Inflammation and Damage in Experimental Arthritis. IJMS 2022;23:8857. [DOI: 10.3390/ijms23168857] [Reference Citation Analysis]
6 Mattei F, Alfaro C, Keisari Y. Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities. Cells 2022;11:459. [DOI: 10.3390/cells11030459] [Reference Citation Analysis]
7 Wang Y, Chu Y, Cao F, Chen Z, Xu H, Wang S, Ma J. The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor. Cent Eur J Immunol 2022;47:373-81. [PMID: 36817396 DOI: 10.5114/ceji.2022.124387] [Reference Citation Analysis]
8 Gallego-Durán R, Montero-Vallejo R, Maya-Miles D, Lucena A, Martin F, Ampuero J, Romero-Gómez M. Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases. Front Immunol 2021;12:667354. [PMID: 34899679 DOI: 10.3389/fimmu.2021.667354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang Z, Zhang L, Shen Y. Identification of immune features of HIV-infected patients with antiretroviral therapy through bioinformatics analysis. Virology 2022;566:69-74. [PMID: 34875552 DOI: 10.1016/j.virol.2021.11.010] [Reference Citation Analysis]
10 Xu D, Yu Y, Xu Y, Ge J. Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient. Diabetes Metab Syndr Obes 2021;14:3555-66. [PMID: 34408457 DOI: 10.2147/DMSO.S323009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Luci C, Vieira E, Bourinet M, Rousseau D, Bonnafous S, Patouraux S, Lefevre L, Larbret F, Prod'homme V, Iannelli A, Tran A, Anty R, Bailly-Maitre B, Deckert M, Gual P. SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis. Cell Mol Gastroenterol Hepatol 2022;13:173-91. [PMID: 34411785 DOI: 10.1016/j.jcmgh.2021.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rai V, Agrawal DK. Regulation of TREM1-Mediated Inflammation in Hepatocellular Carcinoma Cells. Reports 2021;4:17. [DOI: 10.3390/reports4020017] [Reference Citation Analysis]